VIEW THE PROGRAM: AstraZeneca and Oxford University's Partnership on the COVID-19 Vaccine

Date: Monday, September 28, 2020 2:00 pm - 3:15 pm
Duration: 1 Hour, 15 Minutes

BABA AZ OU event 9 28 2020 VIDEO

The British-American Business Association's
Health & Life Sciences Committee

in partnership with the

Swedish-American Chamber of Commerce, Washington, DC

and BABA Platinum Member

AstraZeneca logoC

invites members and colleagues to hear from

AstraZeneca and Oxford University
on their Historic Partnership to develop a Vaccine for COVID-19

DATE:  Monday, September 28, 2020

TIME:  2:00 - 3:15pm ET


Terest Lambe Oxford

Associate Professor Teresa Lambe, The Jenner Institute, Oxford University
Professor Teresa Lambe is a Principal Investigator within the Jenner Institute, based at the University of Oxford. Professor Lambe’s research programme focuses on developing innovative vaccines against emerging and outbreak pathogens. Outside of her most recent work on the ChAdOx1 nCoV-19 (AZD1222) vaccine, her group have progressed novel vaccine development against lethal haemorrhagic viral diseases such as Ebolavirus, Lassa fever virus and Crimean-Congo haemorrhagic fever.
As well as her role in the initial design of the ChAdOx1 nCoV-19 vaccine and leading the pre-clinical testing programme, Professor Lambe’s group are leading critical laboratory studies evaluating the antibody response post-vaccination.
Professor Lambe will discuss Oxford’s pioneering efforts to discover a safe and effective vaccine and their partnership with Astrazeneca.

ann Taylor photo square

Dr. Ann Taylor, Chief Medical Officer, and Head of the AstraZeneca COVID-19 Global Issues Management Team
Ann Taylor is the Chief Medical Officer, R&D at AstraZeneca. Ann is a motivated leader with more than 35 years of experience in exploratory research and early clinical development. She is a skilled physician and has worked for MedImmune as Vice President of Clinical Biologics and held senior roles at Novartis and Pfizer in translational medicine. Ann received her M.D. from Harvard Medical School and has published over 45 journal articles. As part of Ann’s current role, she is accountable for patient safety and R&D quality assurance across the entire AZ portfolio.
Dr Taylor will discuss AstraZeneca’s comprehensive response to the pandemic.